Obesity is a global problem, and trillions are spent every year treating the outcomes of obesity. Weight loss is largely considered an aesthetic goal, weight loss treatments are systemically underfunded, and the health costs associated with obesity – including type 2 diabetes – are often ignored. Habitual wants to tackle obesity by treating the cause and help people lost weight.
The company harnesses innovations in digital therapeutics combined with rigorously validated weight loss tactics to deliver scalable, personalised, and effective treatment for obesity-related health conditions. Habitual's programme combines total diet replacement, digital habit change and virtual social support, and each member of the program is placed in a curated social support group based on careful analysis of each member’s personality, goals, and habit-building style.
Funding has been used to propel user growth, expand team size, and undertake clinical research trials which have helped Habitual go to market. Further, as the cost of diabetes-related healthcare has been by some estimates predicted to surpass $1 trillion a year by 2025, securing even a small portion of this market could result in future success.
Kirsty
Company Specialist at Welcome to the Jungle
